Failure of T stage to predict survival in patients with non-small-cell lung cancer treated by radiotherapy with or without concomitant chemotherapy
International Journal of Radiation Oncology*Biology*PhysicsPublished 1 November 2002
D. Ball, Jennifer Smith, A. Wirth, M Mac Manus
Citations25
SJR quartileQ1
SJR score2.06
SNIP1.72
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
There is some evidence that T stage is an independent prognostic factor in patients with NSCLC treated surgically, but it did not appear to be of value in this series of patients treated with RT with and without concomitant chemotherapy.
Abstract
Although there is some evidence that T stage is an independent prognostic factor in patients with NSCLC treated surgically, it did not appear to be of value in this series of patients treated with RT with and without concomitant chemotherapy.
Keywords
Medicine
CHEST JournalRevisions in the International System for Staging Lung Cancer
4,598 Citations1997Clifton F. Mountain
Analysis of a collected database representing all clinical, surgical-pathologic, and follow-up information for 5,319 patients treated for primary lung cancer confirmed the validity of the TNM and stage grouping classification schema.
CHEST JournalA New International Staging System for Lung Cancer
1,665 Citations1986Clifton F. Mountain
The International Staging System for Lung Cancer provides for classification of six levels of disease extent in five stage groups that relate to patient management and prognosis and can be readily applied in a broad spectrum of clinical and teaching environments.
New England Journal of MedicineEffects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer
1,285 Citations1992C. Schaake-Koning, Walter Van den Bogaert +14 more
Cisplatin, given daily in combination with the radiotherapy described here to patients with nonmetastatic but inoperable non-small-cell lung cancer, improved rates of survival and control of local disease at the price of substantial side effects.
RadiologyMetastases from Non-Small Cell Lung Cancer: Mediastinal Staging in the 1990s—Meta-analytic Comparison Of PET and CT
655 Citations1999Ben A. Dwamena, Seema S. Sonnad +2 more
pooled point estimates of diagnostic performance and summary ROC curves indicated that PET was significantly more accurate than CT for demonstration of nodal metastases (P < .001), and PET is superior to CT for mediastinal staging of non-small cell lung cancer, independent of performance index or clinical context of PET imaging.
CHEST JournalFinal Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer
632 Citations2000William T. Sause, Patricia Kolesar +9 more
Overall survival was statistically superior for the patients receiving chemotherapy and radiation vs the other two arms of the study, and the twice-daily radiation therapy arm, although better, was not statistically superior in survival for those patients receiving standard radiation.
The LancetContinuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial
587 Citations1997Michele I. Saunders, Stanley Dische +4 more
CHART compared with conventional radiotherapy gave a significant improvement in survival of patients with NSCLC, and further improvement may be achieved with dose escalation in conformal radiotherapy, by the addition of cytotoxic chemotherapy, and by hypoxic cell radiosensitisation.
International Journal of Radiation Oncology*Biology*PhysicsAstro plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: A randomized study of 353 patients
267 Citations1991R. Arriagada, Thierry Le Chevalier +10 more
The trial compared arm A, thoracic megavoltage radiotherapy alone at a total dose of 65 Gy in 26 fractions and 45 days, to arm B that comprised the same radiotherapy preceded and followed by 3 monthly cycles of VCPC.
Journal of Clinical OncologyRadiosensitization With Carboplatin for Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: A Phase III Trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group
229 Citations1999Gerald H. Clamon, James E. Herndon +4 more
Carboplatin at the dose and schedule used did not significantly impact on disease control or survival and more effective regimens will be required to impact on local disease control and survival.
CancerF-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma
222 Citations2001Michael P. Mac Manus, Rodney J. Hicks +8 more
The authors investigated FDG‐PET staging in radical RT candidates with unresectable NSCLC and reported high sensitivity and specificity for F‐18 fluorodeoxyglucose (FDG) positron emission tomography (PET) staging in potentially resectableNSCLC.
Radiotherapy and OncologyTumor volume: a basic and specific response predictor in radiotherapy
209 Citations1998Hans-Hermann Dubben, Howard D. Thames +1 more
The data evaluated here suggest that tumor volume is the most precise and most relevant predictor of radiotherapy outcome and its determination is achievable with sufficient accuracy in most radiotherapy departments.
CancerNew aspects in the staging of lung cancer. Prospective validation of the international union against cancer TNM classification
205 Citations1992H. Bülzebruck, Raymond K. Bopp +7 more
The data of 3823 patients were analyzed prospec‐tively in terms of concordance between clinical (TNM) and pathologically confirmed classification (pTNM), the value of the various diagnostic techniques in estimating the pathological confirmed classification, and the prognostic relevance of the new TNM definitions.
International Journal of Radiation Oncology*Biology*PhysicsRecursive partitioning analysis of 1999 radiation therapy oncology group (RTOG) patients with locally-advanced non–small-cell lung cancer (LA-NSCLC): Identification of five groups with different survival
201 Citations2000Maria Werner‐Wasik, Charles Scott +7 more
Cisplatinum-based CT improves survival, for excellent prognosis of LA-NSCLC patients, over RT alone, and the presence of a malignant pleural effusion is a major negative prognostic factor for survival.
Radiotherapy and OncologyA randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial
147 Citations1999David Ball, James F. Bishop +8 more
This study failed to show a significant survival advantage for any of the treatment arms or factors andHalving overall treatment time resulted in significantly greater oesophageal toxicity with no suggestion of a survival advantage.
Journal of Clinical OncologyPhase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol.
145 Citations1995Charles D. Blanke, Rafat Ansari +8 more
Cisplatin, administered every 3 weeks, does not significantly improve response rate, progression-free survival, or overall survival when added to thoracic XRT for locally advanced unresectable NSCLC.
Radiotherapy and OncologyVolume and dose parameters for survival of non-small cell lung cancer patients
80 Citations1997Mary K. Martel, Myla Strawderman +4 more
The data indicate that outcome following radiation may be better predicted by a staging system that takes into account tumor volume and nodal spread rather than a system that is largely based on anatomic location of disease.
European Journal of CancerComparison of induction chemotherapy before radiotherapy with radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung
43 Citations1996Ola Brodin, Nõu E +5 more
The value of the chemotherapy used in this study was very modest, but the results strongly support further research for more efficient drugs and combinations.
CancerEffect of radiologic stage III substage on nonsurgical therapy of non-small cell lung cancer
24 Citations1993Harvey Kreisman, A. Lisbona +6 more
Whether the observed superior survival of selected patients with Stage III NSCLC receiving chemotherapy in addition to radiation therapy (chemo‐RT) was influenced by an imbalance in the radiologic Stage III substage is investigated.
Lung CancerEvaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy
14 Citations1998Jean‐Paul Sculier, Marianne Paesmans +13 more
For unresectable NSCLC treated by induction chemotherapy, stage III sub-classification by moving T4 N0-1 and T1-2 N3 tumours from stage IIIB to stage IIIA appeared to better correlate with prognosis.